1. Home
  2. TSSI vs CADL Comparison

TSSI vs CADL Comparison

Compare TSSI & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TSS Inc.

TSSI

TSS Inc.

HOLD

Current Price

$15.76

Market Cap

315.9M

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$7.13

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TSSI
CADL
Founded
2004
1999
Country
United States
United States
Employees
161
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
315.9M
357.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
TSSI
CADL
Price
$15.76
$7.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$16.00
$19.00
AVG Volume (30 Days)
1.6M
1.6M
Earning Date
05-14-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$3.67
N/A
P/E Ratio
$42.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.50
$4.34
52 Week High
$31.94
$7.66

Technical Indicators

Market Signals
Indicator
TSSI
CADL
Relative Strength Index (RSI) 63.05 74.10
Support Level $15.51 $5.25
Resistance Level $16.28 N/A
Average True Range (ATR) 1.17 0.43
MACD 0.14 0.28
Stochastic Oscillator 82.07 82.85

Price Performance

Historical Comparison
TSSI
CADL

About TSSI TSS Inc.

TSS Inc provides various services for planning, design, development, and maintenance of mission-critical facilities and information infrastructure, as well as integration services. Its services consist of technology consulting, design and engineering, project management, systems integration, systems installation, facilities management, and IT procurement services. The activities are organized into two segments: Procurement, Systems Integration, and Facilities Management. It generates the majority of its revenue from the Procurement segment.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: